Refeeding Syndrome Found Rare in 354 Adults on IV Nutrition
A five-year study of 354 adults on IV nutrition found that up to 13.3% developed refeeding-related low phosphate levels, but zero cases met strict criteria for full refeeding syndrome, according to research published in the European Journal of Clinical Nutrition.
Researchers at North Shore Hospital in Auckland, New Zealand tracked 354 adults who received parenteral nutrition, IV feeding delivered directly into the bloodstream, for more than 48 hours, over a five-year period. Using four diagnostic definitions, the rate of refeeding hypophosphataemia, a drop in blood phosphate after nutrition restarts, ranged from 4.5% to 13.3%, or 17 to 47 of the 354 cases. Zero cases, 0 of 354, met the King's College criteria for full refeeding syndrome. Thirteen cases, 3.7% of the total, showed low phosphate plus fluid overload with no other explanation, which the authors propose may represent a milder, sub-fulminant form of the syndrome.
Refeeding Hypophosphataemia Up To 13.3% vs Refeeding Syndrome 0% in 354 Adults
Refeeding syndrome occurs when reintroducing nutrition after starvation triggers an insulin surge that drives phosphate, potassium and magnesium out of the bloodstream and into cells, according to established clinical understanding of the condition. Low phosphate can affect heart and muscle function, which is why hospitals monitor it closely when starting IV nutrition in malnourished patients. These findings suggest low phosphate after refeeding shows up in a meaningful share of patients depending on the definition used, while the full-blown syndrome doctors have long feared appeared in none of this cohort.
This was an observational study at one hospital, and the factors associated with low phosphate, weight loss, albumin, hemoglobin, came with statistical significance but no reported effect sizes. The reported rate of low phosphate changed more than three-fold depending on which of four definitions was used, and the proposed sub-fulminant category rests on just 13 patients not yet validated elsewhere. Funding was not reported and authors declared no competing interests.
Data Panel
- Who
- 354 adults, age 18 and older, receiving parenteral nutrition for more than 48 hours at a single New Zealand hospital
- Design
- Single-center prospective observational cohort study conducted over five years
- Dose
- Not applicable — observational study of parenteral nutrition, no fixed intervention dose tested
- Primary result
- 4.5% to 13.3% (17 to 47 of 354 cases) met at least one of four criteria for refeeding hypophosphataemia; 0% of cases (0 of 354) met King's College criteria for full refeeding syndrome
- Secondary
- 13 cases (3.7%) had refeeding hypophosphataemia plus unexplained fluid overload, proposed as sub-fulminant refeeding syndrome; weight loss above 10% over three to six months, serum albumin, and serum hemoglobin were associated with refeeding hypophosphataemia, size not reported
- Funding / conflicts
- Authors declared no competing interests; funding source not reported
Dr. Axe's Take
Zero of 354 patients met strict criteria for refeeding syndrome, even though up to 13.3% showed a phosphate drop on a blood draw. That tells me the label gets applied to a lab shift far more often than to a genuine crisis. I still treat refeeding seriously in anyone with major weight loss or an extended stretch without eating, because the insulin surge this study describes really does pull phosphate, potassium and magnesium into cells. If you or a family member is restarting nutrition after significant weight loss, work with your physician on the pace of refeeding and on which labs to track, rather than pushing calories back up on your own.
— Dr. Axe